Your browser doesn't support javascript.
loading
Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies.
Stasilojc, Grzegorz; Felberg, Anna; Urban, Aleksandra; Kowalska, Daria; Ma, Shuo; Blom, Anna M; Lundin, Jeanette; Österborg, Anders; Okrój, Marcin.
Afiliação
  • Stasilojc G; Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1 street, 80-211 Gdansk, Poland.
  • Felberg A; Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1 street, 80-211 Gdansk, Poland.
  • Urban A; Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1 street, 80-211 Gdansk, Poland.
  • Kowalska D; Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1 street, 80-211 Gdansk, Poland.
  • Ma S; Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 675 N St. Clair, Chicago, IL 60611, USA.
  • Blom AM; Department of Translational Medicine, Lund University, Inga Marie Nilssons street 53, 214 28 Malmö, Sweden.
  • Lundin J; Department of Hematology, Karolinska University Hospital Solna, 171 76 Stockholm, Sweden.
  • Österborg A; Department of Hematology, Karolinska University Hospital Solna, 171 76 Stockholm, Sweden.
  • Okrój M; Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Debinki 1 street, 80-211 Gdansk, Poland. Electronic address: marcin.okroj@gumed.edu.pl.
J Immunol Methods ; 476: 112675, 2020 01.
Article em En | MEDLINE | ID: mdl-31629742

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Sistema Complemento / Leucemia Linfocítica Crônica de Células B / Monitorização Imunológica / Anticorpos Monoclonais Humanizados / Fluoresceínas / Alemtuzumab / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Sistema Complemento / Leucemia Linfocítica Crônica de Células B / Monitorização Imunológica / Anticorpos Monoclonais Humanizados / Fluoresceínas / Alemtuzumab / Antineoplásicos Imunológicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article